Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

Bone Marrow Transplantation - Tập 51 Số 6 - Trang 786-792 - 2016
Jakob Passweg1, Helen Baldomero1, Peter Bader2, Chiara Bonini3, Simone Cesaro4, Peter Dreger5, Rafael F. Duarte6, Carlo Dufour7, Jürgen Kuball8, Dominique Farge9, Andrew R. Gennery10, Nicolaus Kröger11, Francesco Lanza12, A Nagler13, Anna Sureda6, Mohamad Mohty14
1Division of Hematology, Department of Medicine, EBMT Activity Survey Office, University Hospital Basel, Basel, Switzerland
2Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt am Main, Germany
3Università Vita-Salute San Raffaele, Milan, Italy
4Paediatric Haematology Oncology, Policlinico G.B. Rossi, Verona, Italy
5Medizinische Klinik V, University of Heidelberg, Heidelberg, Germany
6Hematology Department, Institut Català d’Oncologia, Hospital Duran I Reynals, Barcelona, Spain
7Hematology Unit, G.Gaslini Children’s Institute, Genova, Italy
8Department of Haematology, University Medical Centre, Utrecht, The Netherlands
9Service de Médecine Interne, Maladies Autoimmunes et Pathologie Vasculaire, Hôpital St Louis, Paris, France
10Paediatric Team Children’s BMT Unit, Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle University, Newcastle-Upon-Tyne, UK
11Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany
12Hematology and BMT Unit, Cremona, Italy
13Chaim Sheba Medical Center, Tel-Hashomer, Israel
14Department of Hematology, Hôpital Saint Antoine, Paris, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.

Appelbaum FR . Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472–1475.

Ljungman P, Bregni M, Brune M, Cornelissen J, deWitte T, Dini G et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010; 45: 219–234.

Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617–1624.

Alois G, Marcelo CP, Mahmoud A, Yoshiko A, Helen B, Lydia F et al. One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol 2015; 2: e91–e100.

Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K et al. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174–191.

Gratwohl A . Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197–201.

Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A . Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374–2386.

Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275–291.

Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematologica 2010; 95: 637–643.

Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P et al. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 2014; 49: 744–750.

Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P et al. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant 2015; 50: 476–482.

World Health Organisation, WHO ( http://www.who.int/topics/transplantation/en/ ).

Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M . Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010; 45: 811–818.

Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J et al. Blood and Marrow Transplant Clinical Trials Network. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011; 118: 282–288.

Luznik L, O'Donnell PV, Symons, Chen AR, Leffell MS, Zahurak M et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641–650.

Ballen KK, Verter F, Kurtzberg J . Umbilical cord blood donation: public or private? Bone Marrow Transplant 2015; 50: 1271–1278.

Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47: 906–923.

Anita D’Souza, Angela D, Baldeep W, Mei-Jie Z, Jiaxing H, Morie AG et al. Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a center for International blood and marrow transplant research study. J Clin Oncol 2015; 33: 3741–3749.